Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 4-{[1-Methyl-2,4-Dioxo-6-(3-Phenylprop-1-Yn-1-Yl)-1,4-Dihydroquinazolin-3(2h)-Yl]methyl}benzoic Acid | IC50 | 30000.0 [1] | |
| Benzyl 6-Benzyl-5,7-Dioxo-6,7-Dihydro-5h-[1,3]thiazolo[3,2-C]pyrimidine-2-Carboxylate | IC50 | 30000.0 [1], 100000.0 [2] | |
| Ilomastat | IC50 | 3.4 [1] | |
| (2S)-2-[[8-(Methoxycarbonylamino)dibenzofuran-3-yl]sulfonylamino]-3-methylbutanoic acid | IC50 | 25.0 [1] | |
| N-Hydroxy-N-[1-[1-(2-methylpropyl)piperidin-4-ylidene]-3-[4-[(2-methylquinolin-4-yl)methoxy]phenyl]sulfonylpropan-2-yl]formamide | IC50 | 4000.0 [1] | |
MLA | "Quest Database™ Matrix metalloproteinase 17 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 20 Jan. 2026, https://www.aatbio.com/data-sets/matrix-metalloproteinase-17-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, January 20). Quest Database™ Matrix metalloproteinase 17 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/matrix-metalloproteinase-17-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |